Monocyte chemoattractant proteins (MCP) comprise one of two major CC-chemokine families encoded in the genome as closely linked gene clusters. 'Cluster' chemokines tend to be inflammatory-in contrast to noncluster chemokines, which tend to be homeostatic-although there is some overlap of function 1 . Cluster chemokines often do not correspond exactly between vertebrate species, whereas noncluster and homeostatic chemokines are better conserved across species 1 . Multispecies comparative genomic and phylogenetic analyses of the MCP-encoding cluster suggest that gene duplication and modification occurred within this gene cluster after the branching of rodents and primates 1,2 . The orthologous relationships between mouse and human MCP-cluster chemokines are therefore uncertain 1 . For example, human MCP-4 has no mouse ortholog, and mouse MCP-5 has no human ortholog. The only MCP chemokine not yet functionally characterized is mouse CCL8 (also known as MCP-2 (A001485)).
Monocyte chemoattractant proteins (MCP) comprise one of two major CC-chemokine families encoded in the genome as closely linked gene clusters. 'Cluster' chemokines tend to be inflammatory-in contrast to noncluster chemokines, which tend to be homeostatic-although there is some overlap of function 1 . Cluster chemokines often do not correspond exactly between vertebrate species, whereas noncluster and homeostatic chemokines are better conserved across species 1 . Multispecies comparative genomic and phylogenetic analyses of the MCP-encoding cluster suggest that gene duplication and modification occurred within this gene cluster after the branching of rodents and primates 1, 2 . The orthologous relationships between mouse and human MCP-cluster chemokines are therefore uncertain 1 . For example, human MCP-4 has no mouse ortholog, and mouse MCP-5 has no human ortholog. The only MCP chemokine not yet functionally characterized is mouse CCL8 (also known as MCP-2 (A001485)).
Chemokines and their receptors, in conjunction with adhesion molecules and their ligands, provide cues to enable tissue-specific homing of T cells in the steady state and during inflammation 3, 4 . CCR7 and L-selectin provide T cells with the ability to home to secondary lymphoid organs, CCR9 and integrin α 4 β 7 enhance the ability of T cells to home to the gut, and CCR10 and cutaneous lymphocyte antigen direct T cells to the skin 3, 5 . CCR4 also mediates skin-specific recruitment of T cells in the steady state and during inflammation, in addition to directing T cell recruitment to other organs 3, 5 .
Recent studies on cells isolated from human skin have identified CCR8 (A000631) as an additional CC-chemokine receptor that mediates skin-tropic homing of memory CD4 + , CD8 + and γδ T cells in the steady state 6, 7 and skin-infiltrating leukocytes during atopic A r t i c l e s inflammation 8 . CCR8 is expressed by regulatory T helper cells 9 , CD4 + thymocytes 10 , a subset of dendritic cells and macrophages 11, 12 , and T H 2 (but not T H 1) cells 13, 14 . The role of CCR4 and CCR10 in regulating T cell recruitment to skin is well established 3, 5 . However, whether there is a unique role for CCR8-mediated recruitment of T cells to skin in the steady state or during inflammation has not been established by either in vivo models of inflammation or in vivo trafficking studies. Notably, the skin-tropic viruses molluscum contagiosum and Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) encode a CCR8 antagonist and agonist, respectively 15, 16 .
Here we define mouse CCL8 as a second mammalian agonist for the chemokine receptor CCR8. We also show that human CCL8, a known CCR2 agonist 1, 17 , does not activate CCR8. Mouse CCL8 specifically induces migration of a population of recently activated, highly differentiated T H 2 cells enriched in interleukin 5 (IL-5) and the IL-25 receptor (IL-25R), cytokines implicated in eosinophilic inflammation [18] [19] [20] ; as well as tumor necrosis factor (TNF) and OX40, molecules associated with inflammatory T H 2 cells 21 . Using a model of atopic dermatitis, we demonstrate a pathologic role for CCR8 and mouse CCL8, but not for the T H 2-associated chemokine receptor CCR4 or the previously known mouse CCR8 chemokine ligand mouse CCL1 (TCA3), in mediating chronic cutaneous allergic inflammation. Using competitive in vivo homing experiments, we show that CCR8 and mouse CCL8 direct T H 2 cell recruitment into allergen-inflamed skin and draining lymph nodes (DLNs). Finally, in humans, we show that peripheral blood CCR8 + CD4 + T cells are enriched for IL-5, whereas CCR4 + CD4 + T cells are enriched for IL-4. We thus define mouse CCL8 as a new CCR8 ligand and demonstrate Mouse CCL8 is a CC chemokine of the monocyte chemoattractant protein (MCP) family whose biological activity and receptor usage have remained elusive. Here we show that CCL8 is highly expressed in the skin, where it serves as an agonist for the chemokine receptor CCR8 but not for CCR2. This distinguishes CCL8 from all other MCP chemokines. CCL8 responsiveness defined a population of highly differentiated, CCR8-expressing inflammatory T helper type 2 (T H 2) cells enriched for interleukin (IL)-5. Ccr8-and Ccl8-deficient mice had markedly less eosinophilic inflammation than wild-type or Ccr4-deficient mice in a model of chronic atopic dermatitis. Adoptive transfer studies established CCR8 as a key regulator of T H 2 cell recruitment into allergen-inflamed skin. In humans, CCR8 expression also defined an IL-5-enriched T H 2 cell subset. The CCL8-CCR8 chemokine axis is therefore a crucial regulator of T H 2 cell homing that drives IL-5-mediated chronic allergic inflammation. A r t i c l e s a role for this chemokine in mediating migration of an IL-5-enriched T H 2 cell population into the skin, driving eosinophilic inflammation during chronic allergen exposure.
RESULTS

Gene and protein characterization of mouse CCL8
The human and mouse MCP gene clusters both contain six genes (Fig. 1a) , yet CCL12 (MCP-5) lacks a human ortholog, and CCL13 (MCP-4) lacks a mouse ortholog. In the mouse genome, Ccl8 is positioned between Ccl1, which encodes the only known CCR8 ligand, and Ccl12, encoding a CCR2 ligand. In contrast, in the human genome, CCL8 is positioned between CCL13, encoding a pleiotropic ligand for CCR2, CCR3 and CCR5 receptors, and CCL11 (eotaxin-1), encoding a CCR3 ligand. To search for mouse genes related to human CCL13, we screened an expressed sequence tag (EST) database. The closest hit was the clone identified as mouse Ccl8, which was previously designated as such owing to its sequence homology to human CCL8 (Fig. 1b) . With regard to function, CCL11 recruits eosinophils exclusively through CCR3, and CCL2 recruits monocytes exclusively through CCR2. The other characterized MCP chemokines activate monocytes through CCR2 (refs. 1,17) . CCL7 (MCP-3), CCL13 and human CCL8 also activate eosinophils through CCR3 (ref. 1).
Mouse Ccl8 cDNA was 492 base pairs long, with an open reading frame that encoded 97 amino acids (Supplementary Fig. 1 ). The 5′ region of Ccl8 cDNA encoded a 23-amino-acid hydrophobic leader sequence and had a predicted cleavage site at a position similar to that of other MCP-cluster chemokines. The N terminus of mature mouse CCL8 was predicted to be glycine, a feature shared with CCL12 and human CCL11 but not with other MCP proteins ( Supplementary  Fig. 1) . The mature N-terminal amino acid is important for biological activity and leukocyte selectivity of MCP and eotaxin proteins 22 . Notably, the N terminus of mouse CCL8 was shorter than that of other MCP chemokines by two amino acids but was identical in length to the N terminus of mouse and human CCL11.
We compared mRNA expression of mouse Ccl8 to that of other mouse MCP chemokines and the closely related CC chemokine Ccl11 in normal mouse tissue using RNA hybridization analysis (Fig. 1c) . Ccl8 was the only MCP-family chemokine that had high constitutive expression in skin. Ccl8 mRNA was also detected in thymus, lymph node and breast tissue. Immunofluorescence staining confirmed the presence of mouse CCL8 protein in normal mouse skin (Fig. 1d) , mainly in epidermal keratinocytes.
Screen for mouse CCL8-responsive leukocyte populations
We first observed that bone marrow-derived macrophages (BMDMs) did not migrate in response to mouse CCL8 in in vitro chemotaxis assays, but did migrate to mouse CCL2, which confirmed CCR2 expression on these cells (Fig. 2a) . This finding was unexpected, as all other MCP chemokines activate monocyte lineage cells through CCR2. Baf/3 cells transfected with mouse CCR2 receptor did not migrate to mouse CCL8 in vitro, although they migrated to CCL2 and CCL12 (Supplementary Fig. 2 ), confirming that mouse CCL8 is not a CCR2 agonist. We next assayed mouse eosinophils, which migrate in response to CCL11, for migration to mouse CCL8 because of similarities in the N-terminal structures of CCL8 and CCL11. Mouse CCL8 induced neither migration nor calcium flux of eosinophils isolated from the spleens of Il5-transgenic mice (data not shown), making it unlikely that mouse CCL8 is a CCR3 agonist. We therefore turned to other potential target leukocyte populations to discern the biological activity of mouse CCL8. We assessed the ability of mouse CCL8 to induce the chemotaxis of natural killer (NK) cells, which express functional CCR2 and CCR5. NK cells migrated in response to the CCR2-specific agonist CCL2 and the CCR5-specific agonist CCL4 (MIP-1β), but they did not migrate in response to mouse CCL8, making it unlikely that mouse CCL8 is a CCR5 or CCR2 agonist (Fig. 2b) .
Freshly isolated lymph node CD4 + and CD8 + T cells also did not respond to mouse CCL8 but migrated to the positive control CXCL12 (SDF-1), a CXCR4 agonist (Fig. 2c) . Similarly, T H 1 and T H 2 cells generated by one round of in vitro differentiation, henceforth referred to as T H 1-R1 and T H 2-R1, respectively, did not migrate to mouse CCL8. However, T H 1-R1 cells did migrate to CXCL11 (ITAC; Fig. 2d) , a CXCR3 agonist, and T H 2-R1 did migrate to CCL22 (MDC; Fig. 2e) , a CCR4 agonist, as positive controls. T H 1-R1 and T H 2-R1 cells also 
Human chromosome 17 migrated to CXCL12 and leukotriene B 4 ( Fig. 2d,e and Supplementary  Fig. 3a,b) . T H 1-R1 and T H 2-R1 cells were thus capable of migrating to multiple chemoattractants but specifically could not migrate to mouse CCL8.
A subset of T H 2 cells respond to mouse CCL8 More highly differentiated T H 2 cells, generated by multiple rounds of in vitro polarization followed by T cell receptor (TCR) re-activation, migrate differently than do T H 2-R1 cells 13, 14 . We thus generated such cells, termed T H 2-R2A cells, by in vitro differentiation of T H 2 cells through two rounds of polarization (T H 2-R2), followed by brief TCR reactivation (T H 2-R2A). T H 2-R2A cells migrated potently to mouse CCL8 in a dose-dependent, bell-shaped migration curve (Fig. 2f) . This mouse CCL8-induced chemotaxis was inhibited by pertussis toxin (PTX), an inhibitor of Gα i , indicating that a Gα i -coupled chemoattractant receptor 23 mediates mouse CCL8-induced chemotaxis of T H 2-R2A cells. T H 2-R2A cells also showed robust calcium flux to mouse CCL8 (Fig. 2g) . Dose-response studies revealed that increasing concentrations of mouse CCL8 elicited incremental increases in the magnitude of the calcium flux (Fig. 2h) .
CCR8 mediates mouse CCL8-induced T H 2 cell migration
The migration of T H 2-R2A cells in response to mouse CCL8 provided a tool to identify potential mouse CCL8 receptors. When we assayed CC-chemokine receptor mRNA abundance in mouse CCL8-responsive cells, Ccr8 was the most highly enriched receptor (Fig. 3a) . Signals regulating polarized T helper subset differentiation are tightly linked to expression of chemokine receptors, and CCR8 is expressed on cells of T H 2 (but not T H 1) lineage 3, 4, 13, 14 . However, assaying for CCR8 function in T H 2 cells is confounded by the following factors ( Fig. 3b) : CCR8 induction at levels high enough to mediate agonist function is evident only in T H 2 cells generated by multiple rounds of polarization followed by additional TCR activation 13, 14 ; TCR ligation leads to transient induction of CCR8 expression 13, 14 ; and TCR ligation induces abundant autocrine CCL1 production 24 , which promotes CCR8 receptor desensitization in vitro. Ccr8 mRNA levels were highest in T H 2-R2A cells compared with T H 2-R1 or T H 2-R2 cells, BMDMs, blood monocytes, NK cells or T H 1 cells (Fig. 3c) . Further, T H 1 cells generated by two rounds of polarization or T H 2 cells generated by one round of polarization that underwent additional TCR activation did not migrate to mouse CCL8 ( Supplementary Fig. 3c,d ). These data confirm the specificity of CCR8 expression in T H 2-R2A cells. By comparing migration of wildtype and Ccr8-, Ccr2-or Ccr5-deficient T H 2-R2A cells in response to mouse CCL8, we determined that only deficiency of Ccr8 abrogated migration to mouse CCL8 and the known mouse CCR8 agonist mouse CCL1 (Fig. 3d) . A blocking antibody to mouse CCR8 specifically inhibited migration of wild-type T H 2-R2A cells to mouse A r t i c l e s CCL8 (Fig. 3e) . In contrast, Ccr8 deficiency had no effect on T H 2-R2A cell migration to human CCL8 ( Supplementary Fig. 4a ), consistent with human CCL8 being an agonist for CCR2 (refs. 1,16,17) but not for CCR8.
Mouse CCL8 is a CCR8 agonist Baf/3 cells transfected with mouse Ccr8 showed similar peak migration to mouse CCL8 and CCL1 (Fig. 4a) . Mouse Ccr8 transfectants showed robust and specific calcium flux to mouse CCL8, in a dosedependent manner (Fig. 4b,c) . Signaling induced by mouse CCL8 inhibited subsequent signaling by mouse CCL1, reflecting mouse CCL8-induced desensitization to mouse CCR8 receptor (Fig. 4d) . Likewise, stimulation of mouse Ccr8-transfected Baf/3 cells with mouse CCL1 inhibited subsequent mouse CCL8 signaling. Thus, mouse CCL1 and CCL8 are specific mouse CCR8 agonists. Human CCR8 transfectants migrated to mouse CCL8, albeit more weakly than to human CCL1 (I-309) (Fig. 4e) . Mouse CCL8 induced specific calcium flux in human CCR8-transfected cells and inhibited subsequent signaling by mouse CCL8 (Fig. 4f) . In contrast, human CCL8 did not induce calcium flux or migration of human CCR8-transfected cells ( Fig. 4g and Supplementary Fig. 4b ). Human CCL8 did not inhibit signaling by either mouse CCL8 or human CCL1 ( Fig. 4g) , confirming that human CCL8 was not a human CCR8 agonist, consistent with a prior study 15 . Finally, mouse CCL8 and human CCL1 cross-inhibited signaling in human CCR8-transfected cells (Fig. 4h) . Collectively, these data establish mouse CCL8 as a specific agonist of mouse and human CCR8.
Ccr8 is required for a model of atopic dermatitis
We next addressed the in vivo relevance of the mouse CCL8-CCR8 pathway in a model of chronic cutaneous T H 2 inflammation in which mice underwent three 1-week periods of epicutaneous sensitization with ovalbumin (OVA) at 2-week intervals for a total 7-week period of sensitization 25, 26 (Fig. 5) . Gentle tape stripping at the onset of each 1-week round of sensitization induces cutaneous T H 2 inflammation in this model 25, 26 . OVA-sensitized wild-type mice developed peak inflammation at day 50, 1 d after completion of the third round of topical sensitization, when they manifested cutaneous hyperplasia characterized by a leukocytic infiltrate consisting of eosinophils and CD3 + T cells 25, 26 (Fig. 5a,d ). In contrast, Ccr8 −/− mice were protected from chronic allergic skin inflammation (Fig. 5a,d ). Ccl8 −/− Ccl12 −/− mice were also protected from chronic allergic skin inflammation (Fig. 5b,e) , whereas Ccl12 −/− mice were not (Fig. 5c,e) , suggesting a crucial role for the CCR8 ligand CCL8 in this model. Additionally, Ccr4 −/− mice developed atopic dermatitis similar to wild-type mice (Fig. 5c,e) , and a monoclonal antibody blockade of the other CCR8 ligand CCL1 during the final week of OVA sensitization did not abrogate cutaneous atopic inflammation (Fig. 5f,g ). Thus, the mouse CCL8-CCR8 pathway is essential for promoting chronic cutaneous eosinophilic T H 2 inflammation.
CCR8 regulates eosinophil chemokine expression in skin Less Ccl11 (eotaxin-1) expression was induced in the skin of allergensensitized Ccr8 −/− mice compared to wild-type mice (Fig. 6a,b) , and the induction of Ccl24 (eotaxin-2) expression seen in wild-type mice was abolished in Ccr8 −/− mice (Fig. 6a,b) . Locally recruited T H 2 cells are the source of T H 2 cytokines in this model 25 . Il4 and Il13 expression were similarly induced in OVA-sensitized skin of wild-type and Ccr8 −/− mice relative to PBS-sensitized controls, as were interferon (IFN)-γ (Ifng) and Il17a ( Fig. 6c and Supplementary Fig. 5 ). However, Il5 induction was significantly decreased in Ccr8 −/− mice (P = 0.006). IL-5 is crucial for eosinophil survival and recruitment to peripheral tissue 19 . Fewer infiltrating CD3 + T cells were evident in the skin of OVA-sensitized Ccr8 −/− mice compared to wild-type mice (Fig. 5d ), but these were sufficient for local Il4 induction. OVA-specific IgE induction is IL-4-dependent in this model 25 , and IgE induction was intact in Ccr8 −/− mice (Fig. 6d) . However, OVAspecific IgG 1 antibody production was impaired in Ccr8 −/− mice, consistent with reports of IL-5-dependent IgG 1 class-switching 19 . Thus, the absence of CCR8 led to impaired local recruitment of a subset of IL-5-producing T H 2 cells after allergen rechallenge. The specific defect in eosinophil recruitment and IL-5 induction in 
sensitized Ccr8 −/− mice also led us to measure local IL-25 production (Fig. 6c) . IL-25 is an IL-17-family cytokine important in T H 2 inflammation 18, 20 . Indeed, Il25 was induced in OVA-sensitized skin of wild-type but not Ccr8 −/− mice (Fig. 6c) .
Topical allergen induces local expression of mouse CCL8
We next compared expression of CCR8 ligands in atopic skin to that of chemokine ligands implicated in T cell migration to the skin through the receptors CCR4 and CCR10 (Fig. 6b,e-h) . Mouse CCL8 was the only T cell-attracting chemokine induced in allergen-sensitized skin recovered from both wild-type and Ccr8 −/− mice (Fig. 6b,e-h) . We confirmed the induction of mouse CCL8 protein by immunofluorescence staining. More mouse CCL8 protein was detected in epidermal keratinocytes of wild-type mice compared to Ccr8 −/− mice (Fig. 6f) . Levels of transcripts of the known CCR8 ligand mouse CCL1 (Fig. 6e) , the CCR4 ligands CCL17 and CCL22 (Fig. 6g) , and the CCR10 ligand CCL27 (Fig. 6h) obtained at the same time were not increased, consistent with published reports 26 .
OVA-specific IL-5 + T cells accumulate in Ccr8 −/− DLNs We obtained DLN cells on day 50 at the time of peak skin inflammation. T cells obtained from Ccr8 −/− DLNs produced more IL-5 but equivalent IL-4 after OVA stimulation ex vivo compared to T cells obtained from wild-type DLNs (Fig. 6i) . In contrast, IL-5 levels were equivalent after anti-CD3 activation of DLN T cells. On day 50, after completion of the third round of antigen sensitization, activated and differentiated effector T cells should have acquired migratory capabilities enabling exit from DLNs and entry into inflamed skin. Thus, antigen-specific effector T cells producing IL-5, but not IL-4, accumulated in the DLNs of Ccr8 −/− mice, with a corollary reduction in skin inflammation compared to wild-type mice.
CCR8 and mouse CCL8 mediate T H 2 cell homing in vivo
We compared the in vivo trafficking of adoptively transferred antigen-specific wild-type and Ccr8 −/− T H 2 cells into OVA-sensitized skin and DLNs (Fig. 7a,b) . We detected more wild-type T H 2 cells than Ccr8 −/− T H 2 cells in skin and DLNs 4 d after topical OVA rechallenge. This was reflected by homing indices of 2.8 ± 0.32 and 2.2 ± 0.29 for wild-type T H 2 cells to skin and DLNs, respectively. In contrast, proliferation of antigen-specific wild-type and Ccr8 −/− T H 2 cells in vivo was similar, as measured by bromodeoxyuridine (BrdU) uptake (Fig. 7c) . Because mouse CCL8 was abundantly detected in sensitized skin (Fig. 6) and DLNs (Fig. 7d) and the other CCR8 ligand CCL1 was not, we concluded that mouse CCL8 is the relevant CCR8 ligand mediating the trafficking advantage of wild-type T H 2 cells in vivo. We saw no differences in recruitment to spleens in sensitized mice, where we did not detect mouse CCL8 after sensitization or at baseline (Fig. 7d) . In contrast to T H 2 cells, CCR8 in T H 1 cells did not have a role in recruitment to the skin or DLNs (Fig. 7a,b) , indicating specificity of CCR8 trafficking for T H 2 cells. Notably, 
A r t i c l e s
we did not see a CCR8-dependent difference in the trafficking of CD11c + major histocompatibility complex class II + antigenpresenting cells to skin-draining lymph nodes after tape-stripping and epicutaneous sensitization (Supplementary Fig. 6 ). We also did not see a difference in baseline frequencies of Langerhans cells or γδ T cells in the epidermis, or myeloid or plasmacytoid DCs in the total skin, of Ccr8 −/− or Ccl8 −/− Ccl12 −/− mice compared to wild-type mice (Supplementary Fig. 7 ).
Mouse CCL8 is abundant in skin lymph nodes
We compared baseline expression of the two CCR8 ligands in lymph nodes from various organs (Fig. 7e) . Mouse Ccl1 was not detected in any lymph nodes examined, whereas Ccl8 was present in cervical, mediastinal and skin-draining lymph nodes at concentrations comparable to that of the CCR7 ligand Ccl21, which is known to be important for lymph node homing. Notably, Ccl8 was not detected in mesenteric or gastric lymph nodes, indicating organ specificity of the mouse CCL8-CCR8 lymphoid homing axis. Lastly, we were unable to detect Ccl1 mRNA in normal mouse tissue by quantitative real-time PCR (QPCR), in contrast to the detectable amounts of Ccl8, which was found primarily in the skin and lymphoid tissue outside the gastrointestinal tract (Fig. 7e,f) .
Mouse CCL8-responsive T H 2 cells are enriched for IL-5
Intracytoplasmic cytokine staining (ICS) revealed that wild-type T H 2-R2A cells that expressed CCR8 and responded to mouse CCL8 produced abundant IL-5 compared to IL-4 (Fig. 8a) . We observed a similar profile of T H 2 cytokine production in Ccr8-deficient T H 2-R2A cells (Supplementary Fig. 8 ). Transcripts of the T H 2-regulatory transcription factor Gata3 were more abundant in T H 2-R2 cells than in T H 2-R1 cells (Fig. 8b) . Differential GATA3 levels provide a rationale for the known intrinsic properties of more-differentiated T H 2 cells, such as ease of effector cytokine production 27 and, we propose, ease of CCR8 expression. We examined T H 2-R2A cells for expression of mRNA encoding transcription factors and markers of T H 2 differentiation. We observed a correlation between expression of Ccr8 and Tnfrsf4 (OX40; Fig. 8c ). OX40L-expressing dendritic cells induce the generation of TNF-producing inflammatory T H 2 cells 21 . T H 2-R2A cells produced high levels of TNF but not other T H 2-associated cytokines, such as IL-9 (Fig. 8d) . Notably, mouse CCL8-responsive T H 2-R2A cells were enriched for Il5, Il17rb (IL-25R), Tnfrsf4 (OX40), Tnf and Il1rl1 (interleukin-1 receptor-like 1, also known as IL-33R and T1/ST2) mRNA compared to CXCL12-responsive T H 2 cells in Transwell migration assays (Fig. 8e) . Further supporting these in vitro observations, significantly less Tnf and Tnfrsf4 was evident in OVA-sensitized skin of Ccr8-deficient mice relative to wild-type mice in the model of chronic atopic dermatitis (Fig. 8f) .
We also examined fresh human peripheral blood CD4 + T cells from healthy individuals for T H 2 cytokine production by ICS. CCR8 + CD4 + T cells produced markedly more IL-5 than did total bulk CD4 + T cells (Fig. 8g) . Circulating steady-state CCR8 + CD4 + T cells also produced more IL-5 than IL-4, a pattern shared by IL-25R-and IL1RL1-expressing CD4 + T cell subsets and opposite to the IL-4-predominant T H 2 cytokine expression profiles of CCR4 + and CRTH2 + CD4 + T cell subsets (Fig. 8h) . Moreover, very little IL-5 was produced ex vivo by CCR4 + CD4 + T cell subsets. Of note, in healthy individuals, CCR8 + IL-5 + CD4 + T cells also did not produce IL-13 (data not shown).
DISCUSSION
We have described here the functional characterization of mouse CCL8 and established it as a second mammalian agonist for the chemokine receptor CCR8. We showed that mouse CCL8 was constitutively expressed in the skin and lymph nodes of normal mice in a pattern distinct from that of other related chemokines, reflecting its unique role in regulating immune responses. We determined that recombinant mouse CCL8 was chemotactic for activated, highly differentiated T H 2 (T H 2-R2A) cells specifically through CCR8, and that these cells were enriched for IL-5 and IL-25R, cytokines implicated in eosinophilic inflammation. CCR8 + T H 2 cells were also enriched for OX40 and TNF. The absence of CCR8 or mouse CCL8 was protective, whereas the absence of CCR4 had no impact in a model of chronic allergic dermatitis. Adoptive transfer studies indicated that the mouse CCL8-CCR8 chemokine pathway mediates T H 2 cell recruitment to 
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Ccl8 Ccl27 A r t i c l e s inflamed atopic skin in vivo. Examination of CCR8 on peripheral blood T cells in healthy humans showed that CCR8 + CD4 + T cells were enriched in IL-5 in contrast to CCR4 + CD4 + T cells, which were enriched in IL-4 but not IL-5. The restricted pattern of CCR8 expression in antigen-activated, highly differentiated T H 2 cells, which abundantly produce IL-5 compared to less differentiated T H 2 cells, may be a result of coordinate epigenetic modification of gene loci in these cells. Multiple rounds of polarization enable dual TCR-and IL-4R-activated transcriptional networks to induce epigenetic modifications of the Il4 locus, allowing rapid transcription of effector cytokines upon antigen rechallenge 27 . Epigenetic modifications of the adjacent Il4 and Il13 genes occur simultaneously; in contrast, the Il5 gene is located further away and transcribed in an opposite orientation and is thus regulated differently by the transcription factor GATA3 (refs. 28,29) . CD28 co-stimulation also regulates epigenetic modification and enhanced induction of IL-5 (refs. 28,30), but not IL-4 or IL-13. Transcriptional networks that regulate epigenetic modification of Il5 may regulate the loci encoding CCR8 and IL-25R. Supporting this hypothesis, a recent study using chromatin immunoprecipitation sequencing to study the genome-wide epigenetic effects of STAT4 and STAT6 transcription factor binding during T helper cell differentiation found that Ccr8 is in a rare category of genes containing both STAT4-repressive and STAT6-activating binding sites 31 . Thus, successive rounds of polarization would enable removal of the inhibitory regulation of STAT4 on Ccr8 expression, enabling easier STAT6 induction of Ccr8 expression in more terminally differentiated T H 2 cells.
The role of CCR8 in T H 2 cell migration has been controversial. Our study sheds light on this controversy by highlighting stringent requirements for functional CCR8 expression on T H 2 cells in vitro. In vivo models have also yielded conflicting results regarding the importance of CCR8 in acute models of allergy and T H 2 airway inflammation [32] [33] [34] . However, CCR8-expressing effector T H 2 cells were shown to have a role in a 46-d mast cell-dependent model of chronic allergic airway inflammation 35 . The relative importance of CCR8-regulated responses in different models of allergic airway inflammation may depend on the kinetics of in vivo antigenspecific memory T cell generation 36 . Shorter-term acute models may not capture the differentiation and reactivation of CCR8 hi highly differentiated T H 2 cells.
Our findings point to a link between eosinophils and CCR8 + T H 2 cells in chronic T H 2 inflammation, as sensitized Ccr8 −/− mice have fewer local eosinophils and less local induction of IL-5, IL-25 and the chemokines CCL11 and CCL24. A role for eosinophils in the activation and proliferation of antigen-specific T cells in secondary but not primary immune responses has been observed 37 . A recent study proposed that eosinophils critically regulate T H 2 responses during pulmonary allergen challenge 38 . Eosinophil-derived IL-25 also promotes IL-4-independent activation and effector functions of IL-25R-expressing memory and effector T H 2 cells 20 . IL-25R expression is also enhanced in CD3-and CD28-activated, antigen-experienced human memory T H 2 cells compared to in vitro T H 2 effector cells generated by one round of polarization 20 21 . Mouse CCL8-responsive and CCR8-expressing T H 2 cells in our study were enriched for OX40. OX40-expressing CCR8 + allergen-specific T H 2 cells may be more likely to persist and promote recurrent disease, as OX40 signaling prevents apoptosis and promotes long-term survival of activated T helper cells 39 . This survival advantage may be reinforced by a second anti-apoptotic pathway involving the autocrine production of CCL1 by CCR8 + activated T H 2 cells 40 .
As in many other chemokine systems, the relative role of two CCR8 ligands must now be considered when interpreting in vivo models of inflammation and disease, and their respective roles are likely to depend on differential regulation in vivo. In the model of atopic dermatitis studied here, mouse CCL8 was induced in the skin to levels 2 logs higher than that of mouse CCL1, which was not induced. Moreover, mouse Ccl8 deficient-deficient mice mirrored the defects evident in Ccr8-deficient mice, suggesting that mouse CCL8 was the relevant CCR8 ligand. This conclusion was confirmed by our studies using a CCL1-blocking antibody, which had no influence on the model. In a model of chronic allergic pulmonary inflammation, a neutralizing antibody to mouse CCL1 produced a partial reduction of airway hyperresponsiveness, leading the authors to speculate on the existence of an unidentified CCR8 ligand 35 . In fact, considerable effort has been expended to identify a second CCR8 chemokine ligand. Putative CCR8 ligand assignments have been made, only to be refuted in follow-up studies 41, 42 . Our data convincingly show that mouse CCL8 is the long-sought-after second mouse CCR8 chemokine ligand and is the crucial ligand that mediates CCR8-dependent T H 2 cell trafficking into skin to drive allergic skin inflammation.
The MCP chemokine cluster is not orthologous across the human and mouse genomes. Although human CCL8 is a CCR2 agonist like the other MCPs, we have found that mouse CCL8 is not a CCR2 agonist. Mouse CCL8 did not induce chemotactic activity in BMDMs, CCR2 transfectants or NK cells, all of which responded to the CCR2 agonist CCL2. We also found that human CCL8, in contrast to mouse CCL8, is not a functional CCR8 ligand. Thus, although mouse CCL8 was given the designation orthologous to human CCL8 in the database, our findings establish that they are not orthologous chemokines. However, the mouse and human CCR8 receptors are orthologs, and our findings do not rule out the possibility that there is a second human CCR8 ligand.
Our study expands the current paradigm of T H 2 inflammation by showing that T H 2 cells can be further stratified based on production of IL-5 and IL-4. We propose that CCR8 + T H 2 cells are an IL-5-enriched subset associated with chronic allergic eosinophilic inflammation, whereas CCR4 + T H 2 cells are an IL-4-enriched subset associated with acute IgE-driven allergic inflammation. In support of this concept, we found that blood CCR8 + CD4 + T cells were enriched in IL-5, whereas CCR4 + CD4 + T cells produced abundant A r t i c l e s IL-4 and very little IL-5. Ccr8 −/− mice had diminished IL-5-driven inflammation, independent of IgE production. Two types of allergic inflammation have been described in humans and in mice: an IL-4-and IgE-dependent inflammation, and an IL-5-and eosinophildependent inflammation 43 . Notably, a recent human study found that anaphylactic peanut allergy is associated with a dominant IL-5 − IL-4 + allergen-specific T H 2 cell type associated with IgE responses 44 . Conversely, a dominant IL-5 + IL-4 + food allergen-specific T H 2 cell type is associated with allergic eosinophilic gastroenteritis that is less IgE dependent 44 . Our study provides a relevant parallel to these human studies and provides functional relevance for the reported observation in humans that more CCR8-expressing cells are found in the inflamed skin of individuals with active atopic dermatitis relative to normal skin of healthy individuals 8 . Our findings establish that the diminished atopic inflammation in the skin of Ccr8-deficient mice is a result of a trafficking defect and not the result of decreased functionality of Ccr8-deficient T cells or compromised trafficking or functionality of antigen-presenting cells. Our in vivo and in vitro data show that differentiation and effector function of Ccr8-deficient T H 2 cells were equivalent to wild-type T H 2 cells. In competitive in vivo homing assays, we detected fewer Ccr8-deficient T H 2 cells compared to wild-type T H 2 cells in inflamed skin and DLNs, and we determined that these cells had an equivalent in vivo expansion capacity. Thus, the mouse CCL8-CCR8 homing axis directs T H 2 cell migration to skin and DLNs during cutaneous allergic inflammation.
In conclusion, we define mouse CCL8 as an agonist of CCR8 and show a mouse CCL8-CCR8-directed pathway of T H 2 cell trafficking to the skin in chronic allergic inflammation. We propose a model in which IL-5-and IL-25R-enriched, CCR8-expressing, highly differentiated inflammatory T H 2 cells synergize with locally recruited eosinophils to amplify chronic T H 2 inflammation.
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